Nicholas A. LaBella Jr., MS, RPh, has joined Insmed as chief scientific officer, a newly-created position on the executive team. Mr. LaBella will oversee the scientific and regulatory analysis related to the company’s ongoing strategic review. He reports to Dr. Melvin Sharoky, Insmed’s chairman. Mr. LaBella has approximately 30 years of pharmaceutical industry experience, including drug development, clinical operations and regulatory affairs. Most recently, he served as vice presi...